The mTORC2 Component Rictor Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells

• Akechai Im-aram,

  Affiliation World Class University Biomodulation Major, Department of Agricultural Biotechnology, College of Agriculture and Life Sciences, Seoul National University, Seoul, Republic of Korea

  ⨯
• Lee Farrand,

  Affiliation World Class University Biomodulation Major, Department of Agricultural Biotechnology, College of Agriculture and Life Sciences, Seoul National University, Seoul, Republic of Korea

  ⨯
• Seung-Min Bae,

  Affiliation World Class University Biomodulation Major, Department of Agricultural Biotechnology, College of Agriculture and Life Sciences, Seoul National University, Seoul, Republic of Korea

  ⨯
• Gwonhwa Song,

  Affiliation World Class University Biomodulation Major, Department of Agricultural Biotechnology, College of Agriculture and Life Sciences, Seoul National University, Seoul, Republic of Korea

  ⨯
• Yong Sang Song,

  Affiliation World Class University Biomodulation Major, Department of Agricultural Biotechnology, College of Agriculture and Life Sciences, Seoul National University, Seoul, Republic of Korea

  ⨯
• Jae Yong Han,

  Affiliation World Class University Biomodulation Major, Department of Agricultural Biotechnology, College of Agriculture and Life Sciences, Seoul National University, Seoul, Republic of Korea

  ⨯
• Benjamin K. Tsang

  * E-mail: btsang@ohri.ca

  Affiliations World Class University Biomodulation Major, Department of Agricultural Biotechnology, College of Agriculture and Life Sciences, Seoul National University, Seoul, Republic of Korea, Departments of Obstetrics & Gynecology and Cellular & Molecular Medicine, and the Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada, Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

  ⨯